Stefan Graf

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Journal: Science translational medicine

Published: May 20, 2026

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.

Journal: The Journal of clinical investigation

Published: November 20, 2025

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Journal: Circulation

Published: April 07, 2025

BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity.

BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivity.

Journal: Angiogenesis

Published: April 01, 2025

A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation.

A cautionary note on the naive use of general-population biobanks to study pulmonary arterial hypertension, with a focus on Mendelian randomisation.

Journal: The European respiratory journal

Published: March 06, 2025

Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar.

Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar.

Journal: Human mutation

Published: January 06, 2025

Adaptation of ACMG/AMP guidelines for clinical classification of BMPR2 variants in Pulmonary Arterial Hypertension resolves variants of unclear pathogenicity in ClinVar.

Adaptation of ACMG/AMP guidelines for clinical classification of BMPR2 variants in Pulmonary Arterial Hypertension resolves variants of unclear pathogenicity in ClinVar.

Journal: medRxiv : the preprint server for health sciences

Published: December 09, 2024

Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes.

Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes.

Journal: American journal of respiratory and critical care medicine

Published: December 06, 2024

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).

Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).

Journal: Pulmonary circulation

Published: October 19, 2024

Sex-Specific Genetic Determinants of Right Ventricular Structure and Function.

Sex-Specific Genetic Determinants of Right Ventricular Structure and Function.

Journal: American journal of respiratory and critical care medicine

Published: October 07, 2024

Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension.

Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension.

Journal: bioRxiv : the preprint server for biology

Published: September 30, 2024

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.

Journal: Circulation

Published: August 21, 2024

Showing 1-12 of 74

Last Updated: 09/26/2026